HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.

Abstract
Peroxisome proliferator-activated receptor (PPAR)-delta is a transcription factor that belongs to the PPAR family. PPAR-delta is abundantly expressed in the heart, and its role in the heart is largely unknown. We tested whether pharmacological activation of PPAR-delta protects the heart from ischemia/reperfusion (I/R) injury in male Zucker fatty rats, a rodent model of obesity and dyslipidemia. A highly selective PPAR-delta agonist, [4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl] thio]-2-methylphenoxy]acetic acid (GW0742), was administered for 7 days at 10 mg/kg/day (p.o., once a day). Ischemic injury was produced by occlusion of the left anterior descending artery for 30 min followed by reperfusion for up to 24 h. Treatment with GW0742 reduced serum levels of cardiac troponin-I and infarct size by 63% (p < 0.01) and 32% (p < 0.01), respectively, and improved left ventricular function. Treatment with GW0742 up-regulated gene expression involved in cardiac fatty acid oxidation, increased fat use in the heart, and reduced serum levels of free fatty acids. The enhanced cardiac expression of interleukin (IL)-6, IL-8, intercellular adhesion molecule-1, and monocyte chemoattractant protein-1 induced by I/R were significantly attenuated by GW0742. Treatment with GW0742 also reduced apoptotic cardiomyocytes by 34% and cardiac caspase-3 activity by 61% (both p < 0.01 versus vehicle). GW0742 differentially regulated Bcl family members, favoring cell survival, and attenuated I/R-induced cardiac mitochondrial damage. In addition, GW0742 treatment augmented the cardiac Akt signaling pathway, as reflected by enhanced phospho-3-phosphoinositide-dependent kinase-1 and p-Akt. The results indicate that activation of PPAR-delta protected the heart from I/R injury in Zucker fatty rats, and multiple mechanisms including amelioration of lipotoxicity, anti-inflammation, and up-regulation of prosurvival signaling contribute together to the cardioprotection.
AuthorsTian-Li Yue, Sandhya S Nerurkar, Weike Bao, Beat M Jucker, Lea Sarov-Blat, Klaudia Steplewski, Eliot H Ohlstein, Robert N Willette
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 325 Issue 2 Pg. 466-74 (May 2008) ISSN: 1521-0103 [Electronic] United States
PMID18287212 (Publication Type: Journal Article)
Chemical References
  • Cardiotonic Agents
  • Cytokines
  • Fatty Acids
  • Ketones
  • PPAR delta
  • RNA, Messenger
  • Thiazoles
  • Troponin I
  • (4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cardiotonic Agents (therapeutic use)
  • Cytokines (genetics)
  • Disease Models, Animal
  • Fatty Acids (blood, metabolism)
  • Heart (physiopathology)
  • Ketones (metabolism)
  • Male
  • Metabolic Syndrome (blood, physiopathology)
  • Myocardial Reperfusion Injury (blood, physiopathology, prevention & control)
  • PPAR delta (agonists, physiology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Zucker
  • Thiazoles (therapeutic use)
  • Troponin I (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: